Previous close | 144.41 |
Open | 145.65 |
Bid | 0.00 x 900 |
Ask | 148.60 x 800 |
Day's range | 144.53 - 147.48 |
52-week range | 96.80 - 151.58 |
Volume | |
Avg. volume | 1,634,745 |
Market cap | 43.188B |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | 35.17 |
EPS (TTM) | 4.19 |
Earnings date | 21 May 2024 - 27 May 2024 |
Forward dividend & yield | 0.94 (0.64%) |
Ex-dividend date | 01 Apr 2024 |
1y target est | 145.89 |
Philip Binns, Senior Vice President of Agilent Technologies Inc (NYSE:A), sold 2,827 shares of the company on March 25, 2024, according to a recent SEC Filing.
(Bloomberg) -- Artificial intelligence is set to help bring years of biotech stock underperformance to an end, according to a top European fund manager. Most Read from BloombergTrump’s Net Worth Hits $6.5 Billion, Making Him One of World’s 500 Richest PeopleTrump Vows to Pay Fraud Trial Bond Cut by 68% to $175 MillionVital Baltimore Bridge Collapses After Being Struck by ShipAfter Exposing Realtors, Eliminate the Mortgage Interest DeductionBiden Gains Ground Against Trump in Six Key States, Poll
The fact that multiple Agilent Technologies, Inc. ( NYSE:A ) insiders offloaded a considerable amount of shares over...